Cargando…

Histone deacetylase 6 inhibition counteracts the epithelial–mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis

The role of histone deacetylase 6 (HDAC6) in peritoneal fibrosis remains unknown. In this study, we examined the effect of HDAC6 inhibition on the epithelial–mesenchymal transition (EMT) of peritoneal mesothelial cells and development of peritoneal fibrosis. Treatment with tubastatin A, a highly sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Liuqing, Liu, Na, Gu, Hongwei, Wang, Hongrui, Shi, Yingfeng, Ma, Xiaoyan, Ma, Shuchen, Ni, Jun, Tao, Min, Qiu, Andong, Zhuang, Shougang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687641/ https://www.ncbi.nlm.nih.gov/pubmed/29179471 http://dx.doi.org/10.18632/oncotarget.20982

Ejemplares similares

Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells
por: Shi, Yingfeng, et al.
Publicado: (2021)

Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization
por: Zhou, Xun, et al.
Publicado: (2023)

Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis
por: Shi, Yingfeng, et al.
Publicado: (2021)

Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial‐to‐mesenchymal transition, inflammation and angiogenesis
por: Liu, Feng, et al.
Publicado: (2021)

Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition
por: Wang, Jun, et al.
Publicado: (2017)

Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis
por: Shi, Yingfeng, et al.
Publicado: (2020)

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
por: Zhou, Xun, et al.
Publicado: (2021)

Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells
por: Miyake, Taito, et al.
Publicado: (2020)

Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
por: Shi, Yingfeng, et al.
Publicado: (2022)

Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline
por: Fang, Cheng-Chung, et al.
Publicado: (2012)

Mechanisms of Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells During Peritoneal Dialysis
por: Lee, Hi Bahl, et al.
Publicado: (2007)

Mechanisms of Peritoneal Mesothelial Cells in Peritoneal Adhesion
por: Wang, Ruipeng, et al.
Publicado: (2022)

Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis
por: Liu, An, et al.
Publicado: (2019)

Matrine suppresses lipopolysaccharide-induced fibrosis in human peritoneal mesothelial cells by inhibiting the epithelial-mesenchymal transition
por: Li, Yi-Zheng, et al.
Publicado: (2019)

Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013)

Adrenomedullin in peritoneal effluent expressed by peritoneal mesothelial cells
por: Kono, Rika, et al.
Publicado: (2013)

Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases
por: Li, Junliang, et al.
Publicado: (2022)

The prognosis and risk factors of baseline high peritoneal transporters on patients with peritoneal dialysis
por: Huang, Guansen, et al.
Publicado: (2021)

The Effect of Statin on Epithelial-Mesenchymal Transition in Peritoneal Mesothelial Cells
por: Chang, Tae Ik, et al.
Publicado: (2014)

Effects of tranilast on the epithelial-to-mesenchymal transition in peritoneal mesothelial cells
por: Kang, Seok Hui, et al.
Publicado: (2019)

Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
por: Pascual-Antón, Lucía, et al.
Publicado: (2021)

Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?
por: Loureiro, Jesús, et al.
Publicado: (2013)

MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial–mesenchymal transition (MMT) of human peritoneal mesothelial cells
por: Kimura, Yuki, et al.
Publicado: (2022)

Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho
por: Wang, Qinglian, et al.
Publicado: (2023)

The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer
por: TSUKADA, TOMOYA, et al.
Publicado: (2012)

Fibrosis of mesothelial cell-induced peritoneal implantation of ovarian cancer cells
por: Wang, Jinou, et al.
Publicado: (2018)

Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells
por: Yu, Mina, et al.
Publicado: (2015)

Hydrogen sulfide inhibits epithelial-mesenchymal transition in peritoneal mesothelial cells
por: Cheng, Shengnan, et al.
Publicado: (2018)

Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress
por: Shin, Hyun-Soo, et al.
Publicado: (2017)

Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study
por: Ma, Xiaoyan, et al.
Publicado: (2020)

TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis
por: Lv, Zhi-Dong, et al.
Publicado: (2023)

Delayed administration of suramin attenuates peritoneal fibrosis in rats
por: Xiong, Chongxiang, et al.
Publicado: (2019)

PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation
por: Feng, Junxia, et al.
Publicado: (2022)

Pathophysiological Changes to the Peritoneal Membrane during PD-Related Peritonitis: The Role of Mesothelial Cells
por: Yung, Susan, et al.
Publicado: (2012)

Loosening of the mesothelial barrier as an early therapeutic target to preserve peritoneal function in peritoneal dialysis
por: Kang, Duk-Hee
Publicado: (2020)

Treatment of chronic kidney diseases with histone deacetylase inhibitors
por: Liu, Na, et al.
Publicado: (2015)

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
por: Xie, Shunyun, et al.
Publicado: (2022)

miRNA589 Regulates Epithelial-Mesenchymal Transition in Human Peritoneal Mesothelial Cells
por: Zhang, Ke, et al.
Publicado: (2012)

Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients
por: Ruiz-Carpio, Vicente, et al.
Publicado: (2017)

Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
por: Rynne‐Vidal, Angela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sd07r60h75slojusj3k7hfhr6g